Inclisiran: a small interfering RNA strategy targeting PCSK9 to treat hypercholesterolemia
Yajnavalka Banerjee(University of Dundee), Manfredi Rizzo(University of Palermo), Ali A. Rizvi(Emory University), Arrigo F.G. Cicero(Istituto delle Scienze Neurologiche di Bologna), Anca Pantea Stoian(University of Bucharest), Alexandros Sachinidis(University of Palermo), Dragana Nikolić(Neurosciences Institute), Federica Fogacci(Atatürk University), Andrej Janež(University of Ljubljana)
Cited by 53
Related Papers
Complications of Diabetes 2017
|Journal of Diabetes Research|2018|644
Lipid levels in polycystic ovary syndrome: systematic review and meta-analysis
|Fertility and Sterility|2011|454
Relative Prevalence of Different Androgen Excess Disorders in 950 Women Referred because of Clinical Hyperandrogenism
|The Journal of Clinical Endocrinology & Metabolism|2006|423
Lifestyle recommendations for the prevention and management of metabolic syndrome: an international panel recommendation
|Nutrition Reviews|2017|414
Position paper Statin intolerance – an attempt at a unified definition. Position paper from an International Lipid Expert Panel
|Archives of Medical Science|2015|383